share_log

Citigroup Maintains Neutral on Clover Health Investments, Raises Price Target to $1.5

Benzinga ·  Aug 11, 2023 09:25

Citigroup analyst Jason Cassorla maintains Clover Health Investments (NASDAQ:CLOV) with a Neutral and raises the price target from $1 to $1.5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment